Publications by authors named "Christopher Logothetis"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

9

Total Likes

74

Extended Reach

125,234

Social Features

24
D
Decoding the evolutionary response to prostate cancer therapy by plasma genome sequencing.
Naveen Ramesh, Emi Sei, Pei Ching Tsai, Shanshan Bai, Yuehui Zhao, Patricia Troncoso, Paul G Corn, Christopher Logothetis, Amado J Zurita, Nicholas E Navin

Genome Biol· July 2020

Videos about Article: user

1 23 1

View All Article and Social Media Activity
K
KDM4A promotes NEPC progression through regulation of MYC expression.
Celia Sze Ling Mak, Ming Zhu, Jie Fu, Xin Liang, Xiaoxuan Wang, Christopher J Logothetis

Cancer Lett· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of SGLT2i with Cardiorenal Outcomes Among Diabetics with Prostate Cancer on Hormone Therapy.
Efstratios Koutroumpakis, Rushin Patel, Sumanth Khadke, Aram Bedrosian, Ashish Kumar, Christopher J Logothetis

Cardiovasc Drugs Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Clinical Tools to Monitor Cardiovascular Risk in Men With Prostate Cancer Receiving Hormone Therapy.
Neha Venkatesh, Pankaj Kumar Chauhan, Sagar S Mukhida, Kabir Grewal, Ana Aparicio, Christopher J Logothetis

JCO Oncol Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PKA-driven SPP1 activation as a novel mechanism connecting the bone microenvironment to prostate cancer progression.
Pablo Sanchis, Agustina Sabater, Julia Lechuga, Jimena Rada, Rocio Seniuk, Christopher Logothetis

Oncogene· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body composition as a determinant of the therapeutic index with androgen signaling inhibition.
Andrew W Hahn, Rebecca S Tidwell, Patrick G Pilie, Yao Yu, Jingjing Liu, Christopher J Logothetis

Prostate Cancer Prostatic Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers to optimize PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancer.
Himisha Beltran, Jeremie Calais, Louise Emmett, Phillip H Kuo, Christopher J Logothetis

Front Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leptin levels are associated with coronary artery calcification in patients with advanced prostate cancer.
Efstratios Koutroumpakis, Neha Venkatesh, Ana Aparicio, Juhee Song, Theocharis Panaretakis, Christopher J Logothetis

Oncologist· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node Metastasis.
Amado J Zurita, Rebecca S Tidwell, Brian F Chapin, Deborah R Harris, Miao Zhang, Christopher Logothetis

Eur Urol Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLP-1 Agonist Use Among Men With Localized Prostate Cancer: A Narrative Review and Rationale for Prospective Clinical Trials.
Andrew Fang, Daniel E Frigo, Andrew Hahn, Zayd Razouki, Jessica Hwang, Christopher Logothetis

Urology· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy.
Yuehui Zhao, Naveen Ramesh, Ping Xu, Emi Sei, Min Hu, Christopher J Logothetis

Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histopathologic Progression and Metastatic Relapse Outcomes in Small Cell Neuroendocrine Carcinomas of the Urinary Tract.
Mohammad Jad Moussa, Georges C Tabet, Arlene O Siefker-Radtke, Lianchun Xiao, Nathaniel R Wilson, Christopher J Logothetis

Cancer Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body composition in recurrent prostate cancer and the role of steroidogenic genotype.
Neha Venkatesh, Rebecca S Tidwell, Yao Yu, Ana Aparicio, Amado J Zurita, Christopher J Logothetis

Endocr Relat Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance.
Justin R Gregg, Lisa Newcomb, Ranran Wu, Jennifer Dennison, John W Davis, Christopher Logothetis

Biomark Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial.
Karim Fizazi, Gwénaël Le Teuff, Aude Fléchon, Lance Pagliaro, Josef Mardiak, Christopher Logothetis

J Clin Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates.
Andrew W Hahn, Ganiraju C Manyam, Brian F Chapin, Miao Zhang, Yao Yu, Christopher J Logothetis

BJU Int· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic radiosurgery for prostate cancer spine metastases: local control and fracture risk using a simultaneous integrated boost approach.
Thomas H Beckham, Michael K Rooney, Gizem Cifter, Vincent Bernard, Mary Frances McAleer, Christopher Logothetis

J Neurosurg Spine· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer-induced endothelial-cell-to-osteoblast transition drives immunosuppression in the bone-tumor microenvironment through Wnt pathway-induced M2 macrophage polarization.
Guoyu Yu, Paul G Corn, Celia Sze Ling Mak, Xin Liang, Miao Zhang, Christopher J Logothetis

Proc Natl Acad Sci U S A· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate Cancer.
Ana M Aparicio, Rebecca S S Tidwell, Shalini S Yadav, Jiun-Sheng Chen, Miao Zhang, Christopher J Logothetis

Clin Cancer Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radium-223 Treatment Produces Prolonged Suppression of Resident Osteoblasts and Decreased Bone Mineral Density in Trabecular Bone in Osteoblast Reporter Mice.
Song-Chang Lin, Guoyu Yu, Paul G Corn, Jossana Damasco, Yu-Chen Lee, Christopher J Logothetis

Cancers (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of SGLT-2i with Cardiorenal Outcomes Among Diabetics with Prostate Cancer on Hormone Therapy.
Efstratios Koutroumpakis, Rushin Patel, Sumanth Khadke, Aram Bedrosian, Ashish Kumar, Christopher J Logothetis

Res Sq· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Richard J. Wassersug, Paul F. Schellhammer, and Erik Wibowo's Letter to the Editor re: Christoper J. Logothetis, Andrew W. Hahn. Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome. Eur Urol 2024;85:3-7.
Christopher J Logothetis, Andrew W Hahn

Eur Urol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series.
Nicolas Anselmino, Estefania Labanca, Peter D A Shepherd, Jiabin Dong, Jun Yang, Christopher J Logothetis

Clin Cancer Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone mimetic environments support engineering, propagation, and analysis of therapeutic response of patient-derived cells, ex vivo and in vivo.
Claudia Paindelli, Vanessa Parietti, Sergio Barrios, Peter Shepherd, Tianhong Pan, Christopher J Logothetis

Acta Biomater· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on Enzalutamide.
Wassim Abida, Andrew W Hahn, Neal Shore, Neeraj Agarwal, Paul Sieber, Christopher J Logothetis

Clin Cancer Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Aggressive-Variant Prostate Cancer Molecular Signature in Clinical Laboratory Improvement Amendments (CLIA) Environments.
Paul V Viscuse, Rebecca S Slack-Tidwell, Miao Zhang, Prih Rohra, Keyi Zhu, Christopher J Logothetis

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis